Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Spinal cord injury providers’ perspectives on managing sublesional osteoporosis

Spinal cord injury providers’ perspectives on managing sublesional osteoporosis

The Journal of Spinal Cord Medicine, 2020 · DOI: 10.1080/10790268.2019.1704552 · Published: January 1, 2020

Spinal Cord InjuryMusculoskeletal Medicine

Simple Explanation

Following a spinal cord injury (SCI), individuals often experience a rapid decrease in bone density below the level of injury, leading to osteopenia or osteoporosis. Current guidelines primarily address osteoporosis in postmenopausal women and older men, but there is a lack of specific guidance for managing bone loss in individuals with SCI. This study aimed to understand how healthcare providers manage bone health in their SCI patients, especially given the absence of condition-specific guidelines. The study involved interviewing providers from Veterans Affairs (VA) SCI centers and clinics about their screening, prevention, and treatment strategies for osteoporosis in SCI patients. The interviews revealed that providers often feel limited in their ability to address osteoporosis in SCI patients due to a lack of clear guidelines and effective treatment options. They tend to rely on physical activity, supplements like Vitamin D, and monitoring bone density with DXA scans, particularly when patients are considering new activities or devices.

Study Duration
3 years (FY2014-2016)
Participants
12 SCI providers from VA SCI centers and clinics
Evidence Level
Not specified

Key Findings

  • 1
    There is a lack of standardized guidelines for managing osteoporosis in SCI, leading to variability in screening and treatment approaches among providers.
  • 2
    Providers primarily screen for osteoporosis using DXA scans when patients are considering new devices or activities, or after a fracture has occurred.
  • 3
    FDA-approved medications for osteoporosis are seldom prescribed for SCI patients, with providers citing concerns about their effectiveness and potential side effects in this population.

Research Summary

This study investigated the perceptions and practices of SCI providers regarding the management of sublesional osteoporosis in their patients. It highlights the challenges faced by providers due to the absence of specific guidelines and the limited evidence supporting current osteoporosis treatments in the SCI population. The findings reveal inconsistencies in screening practices, with DXA scans often performed selectively rather than routinely. Vitamin D supplementation is common, but the use of FDA-approved osteoporosis medications is infrequent. The study concludes that there is a need for evidence-informed guidelines to aid providers in osteoporosis management for SCI patients. Future research should focus on identifying effective pharmacological and activity-based interventions to address sublesional osteoporosis and reduce fracture risk in this population.

Practical Implications

Develop SCI-Specific Guidelines

The study emphasizes the urgent need for developing evidence-informed guidelines tailored to the unique challenges of managing osteoporosis in SCI patients. These guidelines should address screening, prevention, and treatment strategies.

Promote Physical Activity and Vitamin D

Encourage physical activity and weight-bearing when possible, along with vitamin D supplementation, as part of a comprehensive approach to managing bone health in individuals with SCI.

Further Research on Interventions

Conduct more research to identify pharmacological and activity-based interventions that are effective in preventing bone loss and reducing fracture risk in the SCI population, including exploring the potential of new medications like romosozumab.

Study Limitations

  • 1
    Small sample size of interviewed providers.
  • 2
    Reliance on provider self-report of practices.
  • 3
    Focus on Veterans Affairs SCI centers and clinics, which may limit generalizability.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury